RAYMOND JAMES & ASSOCIATES - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,938,314
+17.5%
32,801
+11.6%
0.00%0.0%
Q2 2023$2,501,413
-37.2%
29,380
-39.0%
0.00%
-33.3%
Q1 2023$3,982,344
+209.1%
48,125
+193.8%
0.00%
+200.0%
Q4 2022$1,288,287
+43.1%
16,380
+34.8%
0.00%0.0%
Q3 2022$900,000
-52.8%
12,154
-58.5%
0.00%
-50.0%
Q2 2022$1,907,000
-55.9%
29,258
-57.3%
0.00%
-50.0%
Q1 2022$4,327,000
+49.3%
68,448
+25.2%
0.00%
+100.0%
Q4 2021$2,899,000
+322.6%
54,657
+430.9%
0.00%
+100.0%
Q2 2021$686,000
-68.4%
10,295
-47.3%
0.00%
-50.0%
Q1 2021$2,169,000
-6.2%
19,535
+0.3%
0.00%
-33.3%
Q4 2020$2,313,000
+43.8%
19,481
+5.7%
0.00%
+50.0%
Q3 2020$1,609,000
+386.1%
18,439
+398.2%
0.00%
Q2 2020$331,000
-67.6%
3,701
-63.9%
0.00%
-100.0%
Q1 2020$1,021,000
-76.9%
10,240
-73.4%
0.00%
-66.7%
Q4 2019$4,419,000
-17.2%
38,461
-9.1%
0.01%
-14.3%
Q3 2019$5,336,000
+410.1%
42,299
+386.9%
0.01%
+250.0%
Q2 2019$1,046,000
+18.2%
8,688
-14.1%
0.00%
+100.0%
Q1 2019$885,000
-17.4%
10,115
-5.6%
0.00%
-50.0%
Q4 2018$1,072,000
+53.8%
10,716
+76.1%
0.00%
+100.0%
Q3 2018$697,000
-0.4%
6,084
-22.0%
0.00%0.0%
Q2 2018$700,000
+176.7%
7,805
+125.6%
0.00%
Q1 2018$253,0003,4600.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders